Armistice Capital, LLC Sc Pharmaceuticals Inc. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.02 - $7.53 $1.38 Million - $2.59 Million	-344,000 Reduced 13.8%	2,148,000 $15.4 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $931,840 - $1.36 Million	-208,000 Reduced 7.7%	2,492,000 $16.2 Million
Q2 2022 Aug 15, 2022	BUY	$4.3 - $6.48 $11.6 Million - $17.5 Million	2,700,000 New	2,700,000 $13 Million

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $90.2M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.